Novel Experimental and Clinical Therapeutic Uses of Low-Molecular-Weight Heparin/Protamine Microparticles

• Váldodahkkit: Shingo Nakamura (Dahkki), Masanori Fujita (Dahkki), Yasutaka Mori (Dahkki), Hidemi Hattori (Dahkki), Megumi Takikawa (Dahkki), Masayuki Ishihara (Dahkki), Satoko Kishimoto (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2012-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Low-molecular-weight heparin/protamine microparticles (LMW-H/P MPs) were produced as a carrier for heparin-binding growth factors (GFs) and for various adhesive cells. A mixture of low-molecular-weight heparin (MW: approximately 5000 Da, 6.4 mg/mL) and protamine (MW: approximately 3000 Da, 10 mg/mL)...